Select Historical Cash Flow
| SEM Stock | USD 19.83 0.23 1.17% |
Analysis of Select Medical cash flow over time is an excellent tool to project Select Medical Holdings future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Dividends Paid of 54.6 M or Capital Expenditures of 146.4 M as it is a great indicator of Select Medical ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Select Medical Holdings latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Select Medical Holdings is a good buy for the upcoming year.
Select |
About Select Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Select balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Select's non-liquid assets can be easily converted into cash.
Select Medical Cash Flow Chart
Add Fundamental
Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Dividends Paid
The total amount of dividends that a company has paid out to its shareholders over a specific period.Capital Expenditures
Capital Expenditures are funds used by Select Medical Holdings to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Select Medical operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Most accounts from Select Medical's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Select Medical Holdings current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Select Medical Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. At this time, Select Medical's Stock Based Compensation is very stable compared to the past year. As of the 31st of January 2025, Net Borrowings is likely to grow to about 267.5 M, though Change To Inventory is likely to grow to (90.4 M).
| 2022 | 2023 | 2024 | 2025 (projected) | Capital Expenditures | 190.4M | 229.2M | 263.6M | 146.4M | Dividends Paid | 64.6M | 63.9M | 57.5M | 54.6M |
Select Medical cash flow statement Correlations
Click cells to compare fundamentals
Select Medical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Select Medical cash flow statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Sale Purchase Of Stock | (16.0M) | (79.5M) | (195.5M) | (12.8M) | (14.7M) | (15.4M) | |
| Change In Cash | 241.2M | (502.8M) | 23.6M | (13.9M) | (16.0M) | (16.8M) | |
| Free Cash Flow | 881.6M | 220.7M | 94.5M | 352.9M | 405.8M | 426.1M | |
| Change In Working Capital | 479.1M | (330.0M) | (159.5M) | 59.5M | 68.4M | 71.8M | |
| Begin Period Cash Flow | 335.9M | 577.1M | 74.3M | 97.9M | 112.6M | 120.3M | |
| Other Cashflows From Financing Activities | (607.4M) | (713.0M) | 1.1B | (46.9M) | (42.2M) | (40.1M) | |
| Depreciation | 205.7M | 202.6M | 205.8M | 208.7M | 240.1M | 132.1M | |
| Other Non Cash Items | (13.8M) | (7.4M) | (4.8M) | (13.6M) | (12.2M) | (11.6M) | |
| Dividends Paid | 38.6M | 50.6M | 64.6M | 63.9M | 57.5M | 54.6M | |
| Capital Expenditures | 146.4M | 180.5M | 190.4M | 229.2M | 263.6M | 146.4M | |
| Total Cash From Operating Activities | 1.0B | 401.2M | 284.8M | 582.1M | 669.4M | 702.8M | |
| Change To Account Receivables | (116.6M) | 23.1M | (52.2M) | 1.2M | 1.3M | 1.4M | |
| Net Income | 344.6M | 499.9M | 198.0M | 299.7M | 344.7M | 174.2M | |
| Total Cash From Financing Activities | (671.5M) | (647.4M) | (34.9M) | (327.5M) | (294.7M) | (280.0M) | |
| End Period Cash Flow | 577.1M | 74.3M | 97.9M | 84.0M | 96.6M | 110.8M | |
| Stock Based Compensation | 27.3M | 30.9M | 37.8M | 43.8M | 50.4M | 52.9M | |
| Other Cashflows From Investing Activities | 83.3M | (55.1M) | (36.0M) | 163K | 187.5K | 178.1K | |
| Change To Liabilities | 43.0M | 196.2M | (19.8M) | (35.2M) | (40.5M) | (38.5M) | |
| Investments | (31.4M) | (21.0M) | (226.3M) | (256.1M) | (230.5M) | (219.0M) | |
| Change Receivables | (58.0M) | (116.6M) | 23.1M | (52.2M) | (47.0M) | (44.6M) | |
| Net Borrowings | 73.2M | (48.1M) | 195.7M | 264.7M | 238.2M | 267.5M | |
| Total Cashflows From Investing Activities | (316.7M) | (115.4M) | (256.6M) | (226.3M) | (203.7M) | (213.9M) | |
| Cash And Cash Equivalents Changes | 160.7M | 241.2M | (502.8M) | 23.6M | 21.2M | 22.3M | |
| Cash Flows Other Operating | 1.9M | 399.5M | (333.3M) | (72.2M) | (64.9M) | (61.7M) | |
| Change To Netincome | 33.1M | (3.5M) | 26.4M | 38.2M | 34.4M | 34.4M | |
| Change To Operating Activities | 39.2M | 167.7M | (82.8M) | 24.5M | 28.1M | 32.1M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out World Market Map to better understand how to build diversified portfolios, which includes a position in Select Medical Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Select Medical. If investors know Select will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Select Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.139 | Dividend Share 0.5 | Earnings Share 2.14 | Revenue Per Share | Quarterly Revenue Growth 0.057 |
The market value of Select Medical Holdings is measured differently than its book value, which is the value of Select that is recorded on the company's balance sheet. Investors also form their own opinion of Select Medical's value that differs from its market value or its book value, called intrinsic value, which is Select Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Select Medical's market value can be influenced by many factors that don't directly affect Select Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Select Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Select Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Select Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.